5 Best Biotech Stocks to Buy Under $20

4. CymaBay Therapeutics, Inc. (NASDAQ:CBAY)

Number of Hedge Fund Investors in Q4 2022: 35

CymaBay Therapeutics, Inc. (NASDAQ:CBAY) is a biotechnology company developing treatments for diabetes, metabolic diseases, and other health problems. The firm is headquartered in Newark, California.

As of December 2022, 35 of the 943 hedge funds surveyed by Insider Monkey had bought CymaBay Therapeutics, Inc. (NASDAQ:CBAY)’s shares. The firm’s largest hedge fund investor is Kurt Von Emster’s VenBio Select Advisor which owns ten million shares that are worth $64 million.

Follow Cymabay Therapeutics Inc. (NASDAQ:CBAY)